Underuse of Epinephrine Autoinjectors in Anaphylaxis: Who Is to Blame?

Abstract Purpose of ReviewIdentify barriers to epinephrine autoinjector (EAI) use at the healthcare system, health care provider (HCP), and patient and caregiver levels.Recent FindingsEAI prescription, carriage, and use for the treatment of anaphylaxis remain suboptimal. The under-diagnosis of anaphylaxis contributes to suboptimal EAI prescription rates. The high costs of EAIs and concerns about their efficacy, safety, side effects, or …